DSGN Q2 2025 Earnings — Design Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DSGNDesign Therapeutics, Inc.

$569M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$152,000

Operating Income

-$22M

Net Income

-$19M

EPS (Diluted)

$-0.34

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$15M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$223M

Total Liabilities

$10M

Stockholders' Equity

$213M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$152,000	-$151,000	-0.7%
Operating Income	-$22M	-$15M	-43.4%
Net Income	-$19M	-$12M	-61.8%